baber/WOPTO huggingface dataset:
Patent DK-2169241-T3 (DK)
Inventor: GORZA ROBERTO
IPC: A63B22/08
Filed: 2009-09-28
Granted: 2012-02-20
Abstract: A regulating device for gymnastic machines and the like, comprising at least a lever (2) for manual selective lock and release, associated with a first member (3), at least a toothed rod (4), associated to a second member (5) slidable relative to said first member (3), and a pawl (6) mechanically interlocked to the lever (2) and selectively engageable in one of the teeth (7) of the toothed rod (4) to block rigidly the second member (5) with respect to the first member (3) in any position desired by a user; the lever (2) being selectively movable from at least a first position of sliding of the second member (5) relative to the first member (3), wherein said pawl (6) can be released from said toothed rod (4), to at least a second position of blocking said second member (5) relative to said first member (3), wherein the pawl (6) is rigidly engaged in one of the teeth (7) of the toothed rod (4), to at least a third position of substantial clearing of the mechanical backlashes between the second member (5) and the first member (3).
Patent DK-2758060-T3 (DK)
Inventor: MEISSBURGER BETTINA
IPC: A61P3/10
Filed: 2012-09-18
Granted: 2018-03-05
Abstract: The present invention relates to compounds of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment or prevention, suppression or amelioration of a disease mediated by the ROR gamma receptor in a subject in need thereof, in particular diabetes and diabetes- related disorders, specifically type II diabetes, methods of their production, as well as methods of treatment or prevention of such diseases.
Patent DK-2803367-T3 (DK)
Inventor: BLATTLER DR WALTER
IPC: A61K47/48
Filed: 2000-06-23
Granted: 2018-04-16
Abstract: The application concerns methods of treatment using anti-ErbB receptor antibody-maytansinoid conjugates, and articles of manufacture suitable for use in such methods. In particular, the invention concerns ErbB receptor-directed cancer therapies, using anti-ErbB receptor antibody-maytansinoid conjugates.
Patent DK-3129573-T3 (DK)
Inventor: ÅSBO SVEN
IPC: E05F15/608
Filed: 2015-03-25
Granted: 2018-08-06
Abstract: A revolving door assembly (1) comprising a central column (2) and at least one door panel (3) connected to the central column (2) and rotatably arranged around a central axis (X). The central column (2) comprises a support structure (14) and a drive unit (6) including a motor (13) arranged to rotate said at least one door panel (3) around said central axis (X). The support structure (14) is arranged to be mounted to a bottom restriction of an opening in which the revolving door assembly is to be installed. The central column (2) comprises at least one bearing (15, 16) arranged to rotatably support said at least one door panel (3). The motor (13) and the bearing (15,16) are mounted to the support structure (14). A driving base unit (5) for a revolving door assembly (1).
Patent DK-0379978-T3 (DK)
Inventor: NISHIWAKI OSAMU
IPC: C09D11/40
Filed: 1990-01-18
Granted: 1993-10-25
Abstract: A recording liquid containing a dye, glycerine, an aliphatic monohydric alcohol and water. The dye is a mixture of C.I. Food Black 2 and at least one compound selected from compounds which are represented by the following general formulas [I] and [II]: <CHEM> [where Q1 is a phenyl group or a naphthyl group which are substituted by a lower alkyl carbonylamino group and a lower alkoxy group or a naphthyl group substituted by a SO3M group, Q2 is a naphthyl group substituted by a SO3M group or a phenyl group substituted by a lower alkoxy group, Q3 is a phenyl group, a naphthyl group, or a phenyl group or a naphthyl group which are substituted by a SO3M group, R1 and R2 are each a lower alkyl group, a lower alkoxy group or a lower alkyl carbonylamino group, R3 is a hydrogen or a phenyl group substituted by a SO3M group, n is 0 or 1, and M is an alkaline metal or an ammonium cation.
Patent DK-0413223-T3 (DK)
Inventor: ZIPPLIES MATTHIAS DR
IPC: A01N43/40
Filed: 1990-08-06
Granted: 1995-07-10
Abstract: N-Heterocyclomethylspiroheterocycles of the general formula I <IMAGE> (I)  where A is a radical, II, III or IV   <IMAGE> (II) <IMAGE> (III)  or  <IMAGE> (IV)  R2 is CH3, OH or OCH3, n is from 0 to 3, R3 is hydroxyl, acyloxy, alkoxy, unsubstituted or substituted benzoyloxy, unsubstituted or substituted benzyloxy, unsubstituted or substituted alkyl or unsubstituted or substituted alkenyl, unsubstituted or substituted aryl, X is oxygen, sulfur or methylene, Y is hydrogen or hydroxyl, and R1 is hydrogen, alkyl or unsubstituted or substituted cyclohexyl or unsubstituted or substituted phenyl, their addition salts with acids, and fungicides containing these compounds.
Patent DK-0379308-T3 (DK)
Inventor: COHEN MARLENE LOIS
IPC: A61P25/04
Filed: 1990-01-11
Granted: 1992-09-28
Abstract: This invention relates to the use in vivo of 1-isopropyldihydrolysergic acid as a 5-HT2 antagonist.
Patent DK-0457178-T3 (DK)
Inventor: HAMMER KLAUS-DIETER DR
IPC: A22C13/00
Filed: 1991-05-08
Granted: 1994-05-02
Abstract: The tubular casing, especially sausage casing, based on cellulose, possesses a chlorine-free barrier layer against atmospheric oxygen and water vapour. This layer contains a statistical copolymer based on copolymerised vinyl monomers. The vinyl monomers have the general formula CH2 = CR<1>-X, in which 
 
  R<1> is a methyl group or hydrogen and 
  X is a (-OCOR<2>) group or
 is a (-CO2R<2>) group, where 
  R<2> is an alkyl group having 1 to 20, preferably 1 to 10, in particular 1 to 5 C atoms. 
 
<??>In a further embodiment, the copolymer contains, in addition, copolymerised vinyl monomers of the formula mentioned, in which X is a (CO2H) group or a (CO2CN) group.
Patent DK-0520084-T3 (DK)
Inventor: SCHRADE EBERHARD
IPC: E04B1/348
Filed: 1991-07-19
Granted: 1996-05-06
Abstract: In the case of a method for the production of structures and buildings by the modular construction technique and in the case of a dimensionally accurately prefabricated module for carrying out this method, it is proposed to ensure the connection of the individual modules (10) to form a static monostructure by the modules (10) essentially having no bottom and being designed in the manner of a table with corner supports (13a, 13b), if appropriate supplemented by side walls, and, with the modules (10) placed one next to the other and one above the other, by incorporating a continuous horizontal cast-in-situ concrete floor (14, 14') according to the progress of building. In this arrangement, modules (10) may also have any, even oblique, spacings with respect to one another, which are bridged by thin prefabricated intermediate boards (12'), acting as permanent form-work, for the level of poured concrete (14, 14') placed in-situ, which boards are fastened in the respective floor region of adjacent modules (10). <IMAGE>
Patent DK-0467500-T3 (DK)
Inventor: CAMPAU DANIEL N
IPC: B65B39/00
Filed: 1991-03-26
Granted: 1994-01-03
Abstract: An improved apparatus used in a system for filling containers with a required liquid to a predetermined level is disclosed. The apparatus includes an improved main valve means for controlling the flow of liquid through the apparatus and into the container. This improved main valve means includes a a flexible main valve (5), a main valve seat (1), and a main valve support (7) for supporting said flexible main valve (5) to prevent deflection of said main valve (5) away from said seat (1). <IMAGE>
Patent DK-0484186-T3 (DK)
Inventor: MASTERSON JOSEPH GERARD
IPC: A61K9/26
Filed: 1991-11-01
Granted: 2000-04-17
Abstract: Pharmaceutical formulations comprise a mono- or di-aminopyridine active agent for administration on a once- or twice-daily basis for use in the treatment of neurological diseases, in particular multiple sclerosis and Alzheimer's disease. The formulations, which are suitable for oral or percutaneous administration of the active agent, include the active agent in a carrier effective to permit release of the mono- or di-aminopyridine at a rate allowing controlled absorption thereof over, on the average, not less than a 12 hour period and at a rate sufficient to achieve therapeutically effective blood levels over a period of 12-24 hours following administration.
Patent DK-0461012-T3 (DK)
Inventor: GEORGE PASCAL
IPC: A61K31/495
Filed: 1991-06-03
Granted: 1994-09-12
Abstract: [(1-Arylpyrrolidin-2-yl)methyl]piperazine compounds corresponding to the formula   <IMAGE> (I)  in which Z denotes a group of formula N-R1 in which R1 is either a hydrogen atom or a C1-3 alkyl group or a group of formula Ar-CnH2n in which n denotes 0, 1 or 2 and Ar denotes a phenyl group optionally substituted by one or more halogen atoms and/or C1-3 alkyl or C1-3 alkoxy radicals, or a group of formula COR2 in which R2 denotes the CH3, C6H5, CH2C6H5 or OC2H5 group and their salts of addition to pharmaceutically acceptable acids. The compounds are useful for the treatment of neurological disorders.
Patent DK-0528877-T3 (DK)
Inventor: SPINELL MAX
IPC: G01N21/64
Filed: 1991-05-06
Granted: 1995-07-31
Abstract: PCT No. PCT/DK91/00120 Sec. 371 Date Jun. 10, 1991 Sec. 102(e) Date Jun. 10, 1991 PCT Filed May 6, 1991 PCT Pub. No. WO91/17422 PCT Pub. Date Nov. 14, 1991.An apparatus and a method for analyzing particles suspended in a liquid are described, which particles are of a type or are prepared so as to emit radiation characteristic of the particles when exposed to radiation. Particular fluorescence-photometrical flow cytometry is described in connection with biological cell populations. The apparatus comprises an elongated flow area in the shape of a channel provided in a cuvette comprising a first body member having a planar facial surface and a second body member having a planar facial surface. The first and the second body members are adapted to be moved relative to one another between a first position, in which the planar facial surfaces are in fluid-tight contact with one another, and a second position, in which the planar facial surfaces are spaced apart. At least one of the planar facial surfaces of one of the body members is provided with an elongated groove. In the first position, the first and second body members together define the cuvette in which the elongated flow area is defined by the elongated groove constituting a capillary passage. An inlet for feeding the liquid to the elongated flow area is provided in one of the body members and an outlet for discharging the liquid from the elongated flow area is provided in the very same or in the other body member. At least one of the body members is transparent to light to which the particles are exposed and further transparent to the radiation emitted by the particles. Two electrodes are further described for carrying out an election of particles suspended in the liquid by means of a measurement of the electrical conductivity of the fluid, which particles are of a specific size for subsequent registration of fluorescence when exposed to radiation.
Patent DK-0502325-T3 (DK)
Inventor: SCHIMMEL GUENTHER DR
IPC: C01B33/32
Filed: 1992-02-04
Granted: 1995-01-09
Abstract: For the preparation of crystalline sodium silicates having a layer structure, an SiO2/Na2O molar ratio of (1.9 to 2.1):1 and a water content of less than 0.3% by weight from a waterglass solution obtained by reacting sand with sodium hydroxide solution in an SiO2/Na2O molar ratio of (2.0 to 2.3):1 and having a solids content of at least 20% by weight, the waterglass solution is treated in a spray-drying zone with hot air at 200 to 300 DEG C to form a pulverulent, amorphous sodium silicate having a water content (determined as loss on ignition at 700 DEG C) of 15 to 23% by weight. The pulverulent, amorphous, water-containing sodium silicate is first ground, preferably to grain sizes of 1 to 50  mu m, before it is introduced into a rotary kiln in an inclined arrangement and treated therein with flue gas in countercurrent at temperatures of more than 500 to 850 DEG C, to form crystalline sodium silicate. The sodium silicate emerging from the rotary kiln is first comminuted to grain sizes of 0.1 to 12 mm and finally ground to grain sizes of 2 to 400  mu m.
Patent DK-0504982-T3 (DK)
Inventor: CIMINO ROBERTO
IPC: C10G21/00
Filed: 1992-03-11
Granted: 1994-08-01
Abstract: A continuous process for deasphalting and demetallating a residue from crude oil distillation, by means of dimethyl carbonate as extraction solvent, comprises:   mixing a residue from crude oil distillation with a recycled liquid stream containing oil and dimethyl carbonate, in order to produce a homogeneous solution; cooling said homogeneous solution and separating a refined light, liquid, phase; an extracted middle phase; and a heavy phase containing asphaltenes; recovering a primary, deasphalted/demetallated oil from said light phase; partially recycling said middle phase to the mixing step, and recovering a secondary deasphalted oil from the residual fraction;   recovering asphaltenes from said heavy phase.   <IMAGE>
Patent DK-0570489-T3 (DK)
Inventor: GUERIN-MARCHAND CLAUDINE
IPC: C07K14/445
Filed: 1992-02-05
Granted: 2000-01-03
Abstract: The present invention relates to an in vitro diagnostic method for malaria in an individual comprising placing a tissue or a biological fluid taken from an individual in contact with a molecule or polypeptide composition, wherein said molecule or polypeptide composition comprises one or more peptide sequences bearing all or part of one or more T epitopes of the proteins resulting from the infectious activity of P. falciparum, under conditions allowing an in vitro immunological reaction to occur between said composition and the antibodies that may be present in the tissue or biological fluid, and in vitro detection of the antigen-antibody complexes formed. The invention further relates to a polypeptide comprising at least one T epitope from a liver-stage specific protein produced by P. falciparum and a vaccine composition directed against malaria comprising a molecule having one or more peptide sequences bearing all or part of one or more T epitopes resulting from the infectious activity of P. falciparum in the hepatic cells.
Patent DK-0607244-T3 (DK)
Inventor: COLLINS BRIAN JOHN
IPC: C03C17/245
Filed: 1992-10-12
Granted: 1999-09-27
Abstract: PCT No. PCT/GB92/01858 Sec. 371 Date Apr. 8, 1994 Sec. 102(e) Date Apr. 8, 1994 PCT Filed Oct. 12, 1992 PCT Pub. No. WO93/07099 PCT Pub. Date Apr. 15, 1993Sheet glass (2) is rendered fire resistant such that it will not shatter under a build-up of heat to 900 DEG  C., by providing a thin coating (1) on one or both its surfaces, the coating being stable and adherent to the glass at up to 900 DEG  C., the coating preferably comprising an oxide, nitride, oxynitride or fluoride of a metal or of silicon, or a metal silicide, the sheet having been toughened by tempering before or after coating and having its edges (3) ground and polished before the tempering step to remove all imperfections therefrom.
Patent DK-0667902-T3 (DK)
Inventor: WALDMANN HERMAN
IPC: C07K16/00
Filed: 1992-12-04
Granted: 2003-04-22
Abstract: PCT No. PCT/GB92/02251 Sec. 371 Date Jun. 3, 1994 Sec. 102(e) Date Jun. 3, 1994 PCT Filed Dec. 4, 1992 PCT Pub. No. WO93/11237 PCT Pub. Date Jun. 10, 1993.A humanised antibody is provided in which the amino acid sequence of the CDRs is derived from the sequence of CDRs of a monoclonal antibody having the specificity of binding to resting and activated T-cells, inhibiting T-cell proliferation and lysing T-cells from mice transgenic for human CD2 and in which sufficient of the amino acid sequence of each CDR has been retained to provide the same specificity for the humanised antibody.
Patent DK-0564303-T3 (DK)
Inventor: CROSSDALE GARRY WILLIAM
IPC: B65D23/10
Filed: 1993-04-02
Granted: 1996-05-06
Abstract: The application describes a container which is adapted for suspension by its upper region below a filling head (3) of a dispenser, the container being characterized by register means (348) on a side wall thereof for interengaging with complementary register means (34) on a container support of the dispenser, registration of the register means allowing for alignment of the container below the filling head for filling of the container. The register means can comprise a number of pins or recesses in the side wall of the container for registration with complementary recesses or pins on the container support of the dispenser. <IMAGE>
Patent DK-0621786-T3 (DK)
Inventor: SACHS DAVID H
IPC: A61K35/26
Filed: 1993-01-07
Granted: 2002-04-29
Abstract: The invention features a method designed to lengthen the time an implanted organ (a xenograft) survives in a xenogeneic host prior to rejection. Preparation of the recipient for transplantation includes the following steps: First, the recipient is administered low dose radiation. Second, an antibody preparation that binds T cells and NK cells is injected into the recipient. Third, natural antibodies are absorbed from the recipient's blood by hemoperfusion of an organ of the donor species. Fourth, hematopoietic stromal tissue of the donor species is administered to the recipient. Fifth, donor hematopoietic stem cells are injected into the recipient. Finally, the xenograft organ is implanted into the recipient mammal. Best results are obtained when all steps are used in combination.
Patent DK-0611278-T3 (DK)
Inventor: KLASEN ANTON
IPC: A01D82/00
Filed: 1993-06-16
Granted: 1997-02-24
Abstract: In order to prepress grass, hay or other soft vegetable parts lying in swaths, already on the meadow or fields a device has two adjacent crushing devices (1, 2) rotative around vertical axes and whose rotating crushing surfaces cooperate in such a way that the material to be crushed is pulled in between the crushing surfaces and compressed during driving. At least one crushing device is driven by a motor. A pressure roller (10) rotative around a horizontal axis is arranged before and above the crushing devices in the direction of travel. The crushing devices may be designed as wheels that turn in opposite directions and are provided with an elastic envelope or as revolving endless belts (17, 18). This prepressing device can be attached to a farming vehicle.
Patent DK-0664400-T3 (DK)
Inventor: MUNSCH STEFAN
IPC: F04D29/04
Filed: 1994-12-01
Granted: 1999-10-11
Abstract: The magnet-operated pump is suitable for use with corrosive media. It has a pump shaft (26) made of hard ceramic material. Its journal bush (28) adjacent to the impeller (38) has a first free ring-shaped end bearing face (34) facing the impeller. The pump shaft bearing (30) adjacent to the magnet-rotor (18) has a second end face bearing surface (32). An impeller bush (36) fixed to the impeller is also made of hard ceramic material, and has a first axial bearing face (40) pointing towards one of the first end bearing faces (34). A hard ceramic bush (22) is fixed to the magnet-rotor, having a free second axial bearing face (24) facing the second end bearing face.
Patent DK-0611003-T3 (DK)
Inventor: OK HYUN O
IPC: A61K31/415
Filed: 1994-02-03
Granted: 1997-08-25
Abstract: Substituted phenylsulphonamides having the formula: <CHEM>  where the variables are as defined in Claim 1;   are selective beta-3 adrenergic receptor agonists with very little beta-1 and beta-2 adrenergic receptor activity and as such the compounds are capable of increasing lipolysis and energy expenditure in cells. The compounds thus have very potent activity in the treatment of Type II diabetes and obesity. The compounds can also be used to reduce triglyceride levels and cholesterol levels or raise high density lipoprotein levels or to reduce gut motility. In addition, the compounds can be used to reduce neurogenic inflammation or as antidepressant agents. The compounds are prepared by coupling an aminoalkylphenylsulphonamide with an appropriately substituted alkyl epoxide. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for reduction of triglyceride levels and cholesterol levels or raising high density lipoprotein levels or for increasing gut motility are also disclosed.
Patent DK-0680320-T3 (DK)
Inventor: MILLS NANCY
IPC: A61K31/40
Filed: 1993-12-20
Granted: 1999-10-25
Abstract: An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981 Hemi-Calcium, of formula (IA)   <IMAGE>   with effective amounts of calcium carbonate. A method for preparing a CI-981 stabilizing composition is described.
Patent DK-0727973-T3 (DK)
Inventor: KININMONTH JULIA
IPC: D03D15/56
Filed: 1994-11-04
Granted: 2000-07-31
Abstract: PCT No. PCT/GB94/02427 Sec. 371 Date May 1, 1996 Sec. 102(e) Date May 1, 1996 PCT Filed Nov. 4, 1994 PCT Pub. No. WO95/13038 PCT Pub. Date May 18, 1995There is disclosed a woven bandage which exhibits a crepe effect and which contains elastomeric yarns and composite warp yarns (1) wherein the composite yarns comprise a staple fibre yarn (2) and a textured filament yarn (3) twisted together. The staple fibre yarn (2) forms loops (4) which gives the bandage a crepe effect. There is also described a process for manufacture of such bandages.
Patent DK-0751861-T3 (DK)
Inventor: PRENGER JAN HENDRIK
IPC: B29C48/90
Filed: 1995-03-17
Granted: 2002-03-18
Abstract: PCT No. PCT/NL95/00100 Sec. 371 Date Nov. 18, 1996 Sec. 102(e) Date Nov. 18, 1996 PCT Filed Mar. 17, 1995 PCT Pub. No. WO95/25627 PCT Pub. Date Sep. 28, 1995Method and device for manufacturing biaxially oriented tubing from thermoplastic material. The method includes forcing the tube over a mandrel at an orientation temperature of the plastic material, which mandrel includes an expansion part which produces expansion in the circumferential direction of the tube, and downstream of the mandrel the exertion of an axial pulling force on the tube, in the course of which the tube encounters a resistance which counteracts the movement of the tube over the mandrel. The method also includes the exertion of an influence sector-wise in an adjustable manner in the circumferential direction of the tube on the resistance which counteracts the movement of the tube over the mandrel. In an advantageous embodiment, the temperature of the plastic material of the tube is influenced sector-wise in an adjustable manner, viewed in the circumferential direction of the tube. The measures according to the invention lead to better control over the manufacture of biaxially oriented tubing.
Patent DK-0788348-T3 (DK)
Inventor: UNGER EVAN C
IPC: A61M5/31
Filed: 1995-07-26
Granted: 2004-11-29
Abstract: A container comprising an aqueous lipid suspension and a gaseous phase substantially separate from the aqueous stabilizing phase, useful in diagnostic imaging such as ultrasound and magnetic resonance imaging and in therapeutic applications, is disclosed.
Patent DK-0776974-T3 (DK)
Inventor: NOBUFUSA SERIZAWA SANKYO COMPA
IPC: C12N15/11
Filed: 1996-11-29
Granted: 2003-08-25
Abstract: A 1 kbp length of the 5'-noncoding region of the gene encoding cytochrome P-450sca-2 in the actinomycete Streptomyces carbophilus has transcription promoter activity which is substrate inducible. When the 1 kbp region is shortened, transcription activity becomes constitutive and the shortened promoters can be used advantageously in expression systems, especially those expressing P-450sca-2 in the presence of ML-236B to produce pravastatin sodium.
Patent DK-0745750-T3 (DK)
Inventor: DEMARS YVES
IPC: E06B3/54
Filed: 1996-05-31
Granted: 2001-05-21
Abstract: The window has two glass panels joined together with spacers and seals between their inner surfaces. One inner element (17) is attached to the panels by butyl joints (19), for example, separated from an inner spacer frame member (15) by a polysulphide elastomer strip (18). The inner spacer frame member (15) has elastomer seals (21) between it and the glass panels, and is attached to an outer surrounding frame (14) by fixing screws (16). The outer glass panel (20) of the window can be larger than the inner one, with its edge overlapping part of the surrounding frame.